Skip to main content
SpringerLink
Log in

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

  • Commentary
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

REFERENCES

  1. Williams PD. Darwinian interventions: taming pathogens through evolutionary ecology. Trends Parasitol. 2010;26:83–92.

    Article  PubMed  Google Scholar 

  2. Thiel K. Old dogma, new tricks—21st Century phage therapy. Nat Biotechnol. 2004;22:31–6.

    Article  PubMed  CAS  Google Scholar 

  3. Sulakvelidze A, Alavidze Z, Morris Jr JG. Bacteriophage therapy. Antimicrob Agents Chemother. 2001;45:649–59.

    Article  PubMed  CAS  Google Scholar 

  4. Chanishvili N, Sharp R. Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. A literature review of the practical application of bacteriophage research. Tbilisi: Eliava Foundation; 2009.

    Google Scholar 

  5. Górski A, Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Lobocka M, Fortuna W, et al. Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs. 2009;10:766–74.

    PubMed  Google Scholar 

  6. Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay J-P. European regulatory conundrum of phage therapy. Future Microbiol. 2007;2:485–91.

    Article  PubMed  CAS  Google Scholar 

  7. Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol. 2010;11:69–86.

    Article  PubMed  CAS  Google Scholar 

  8. Merabishvili M, Pirnay J-P, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE. 2009;4:e4944.

    Article  PubMed  Google Scholar 

  9. Buckling A, Rainey PB. Antagonistic coevolution between a bacterium and a bacteriophage. Proc Biol Sci. 2002;269:931–6.

    Article  PubMed  Google Scholar 

  10. Wood JM, Levandowski RA. The influenza vaccine licensing process. Vaccine. 2003;21:1786–8.

    Article  PubMed  CAS  Google Scholar 

  11. Akst J. Key cancer patents killed. http://www.the-scientist.com/blog/display/57265/ (accessed 19/10/10), part of The Scientist. http://www.the-scientist.com/ (accessed on 19/10/10).

  12. Levin BR, Bull JJ. Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol. 2004;2:166–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Molecular and Cellular Technology Burn Wound Centre, Queen Astrid Military Hospital, 1120, Brussels, Belgium

    Jean-Paul Pirnay, Daniel De Vos, Gilbert Verbeken & Maia Merabishvili

  2. Eliava Institute of Bacteriophage, Microbiology and Virology, 380060, Tbilisi, Georgia

    Maia Merabishvili, Nina Chanishvili & Revaz Adamia

  3. Laboratory of Bacteriology Research, Faculty of Medicine, Ghent University, 9000, Ghent, Belgium

    Maia Merabishvili & Mario Vaneechoutte

  4. Department of Physiology, Free University Brussels, 1090, Brussels, Belgium

    Martin Zizi

  5. Section Health of the Division Well-Being (Belgian Defence Staff), Queen Astrid Military Hospital, 1120, Brussels, Belgium

    Martin Zizi

  6. Office of the Surgeon General, Belgian Defence, 1140, Evere, Belgium

    Geert Laire

  7. Laboratory of Gene Technology, Katholieke Universiteit Leuven, 3001, Leuven, Belgium

    Rob Lavigne

  8. Faculty of Law, Centre for Intellectual Rights, Catholic University of Leuven, 3000, Leuven, Belgium

    Isabelle Huys

  9. Laboratory of Pharmacotechnology and Biopharmacy, Catholic University of Leuven, Herestraat 49, 3000, Leuven, Belgium

    Guy Van den Mooter

  10. Department of Zoology, University of Oxford, Oxford, OX1 3PS, UK

    Angus Buckling

  11. Department of Microbiology Molecular Biology of the Gene in Extremophiles Unit, Institut Pasteur, 75724, Paris, France

    Laurent Debarbieux

  12. Pherecydes Pharma, 93230, Romainville, France

    Flavie Pouillot

  13. Institute for Biotechnology & Bioengineering Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057, Braga, Portugal

    Joana Azeredo

  14. Phage Biology Lab, The Evergreen State College, Olympia, Washington, 98505, USA

    Elisabeth Kutter

  15. Laboratoire de Microbiologie, Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges, 94195, Villeneuve Saint-Georges, France

    Alain Dublanchet

  16. Transplantation Institute, The Medical University of Warsaw Institute of Immunology and Experimental Therapy, Polish Academy of Sciences Wroclaw, Wroclaw, Poland

    Andrzej Górski

Authors
  1. Jean-Paul Pirnay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel De Vos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gilbert Verbeken
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maia Merabishvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nina Chanishvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mario Vaneechoutte
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Martin Zizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Geert Laire
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rob Lavigne
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Isabelle Huys
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Guy Van den Mooter
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Angus Buckling
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Laurent Debarbieux
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Flavie Pouillot
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Joana Azeredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Elisabeth Kutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Alain Dublanchet
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Andrzej Górski
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Revaz Adamia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guy Van den Mooter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pirnay, JP., De Vos, D., Verbeken, G. et al. The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?. Pharm Res 28, 934–937 (2011). https://doi.org/10.1007/s11095-010-0313-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0313-5

KEY WORDS

Search

Navigation